PKM and Sepsis: Inhibition of aerobic glycolysis by either 2-deoxy-d-glycose (2-DG) or PKM2 inhibitor also markedly improves survival outcome in polymicrobial sepsis, and reduces serum lactate levels and HMGB1 release (46).